The Latest Breaking News on Pharma

FTSE-listed pandemic halo firm said it is empowering biologics delivery in health care with Staffordshire and US expansion underway

Uganda has had multiple Ebola outbreaks, including one in 2000 that killed more than 200 people

Indonesia is in talks with several African countries, including Nigeria, to export and donate its homemade COVID-19 vaccine, its developer said on Friday, after becoming the first country in Southeast Asia to approve a domestically developed COVID shot.

A "game-changing" drug that hit the Pharmaceutical Benefits Scheme (PBS) last week has already helped Newcastle's Carters family, the first in Australia to trial a weekly growth hormone injection called Ngenla.

A select list of stories to read before you start your day

BioNTech has stuck an in-principle partnership with the Victorian government to establish an mRNA manufacturing facility in Melbourne.

The mounting economic toll of China's zero-COVID policy is raising investor hopes that Beijing may finally begin laying the groundwork for the tricky epidemiological and political task of shifting course following this month's Communist Party congress.

The World Health Organisation says the contaminated medications may have been distributed outside of the West African country, and global exposure could well be ‘possible’.

Officials note that risk of Ebola outbreak in US remains low and no cases have been confirmed outside Uganda.

Favorable federal investments are anticipated to fuel further expansion in the biotech industry. Given the sector’s good prospects, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys. However, fundamentally weak stock Intra-Cellular Therapies (ITCI) might be best avoided. Read on….

A new COVID-19 wave appears to be brewing in Europe as cooler weather arrives, with public health experts warning that vaccine fatigue and confusion over types of available vaccines will likely limit booster uptake.